Wellbutrin Retard

Quick links

Choose a section

Quick links to important sections

Advertisements

Wellbutrin Retard

Advertisements
Advertisements

Method of action: Antidepressant, Psychoanaleptics

Advertisements

Overview of Wellbutrin Retard

Property Description
Active ingredient Bupropion Hydrochloride
Form Sustained-release tablet (SR)
Pharmacological class Atypical antidepressant (NDRI)
Common use Management of depressive illness
Origin Synthetic (Aminoketone derivative)

Understanding the Atypical Antidepressant Class

Wellbutrin Retard is a prescription-only psychotropic medicine containing the single active ingredient Bupropion Hydrochloride, clinically recognized for its role in the management of depressive illness. It is formally classified as an atypical antidepressant because its pharmacological action is distinct from other major antidepressant groups. This medication belongs to the aminoketone chemical class and is a synthetic compound. Bupropion is an aminoketone with a structure distinct from other antidepressants. This indicates the medicine works differently from many other medications used for mood.

Composition and the Role of Bupropion Hydrochloride

Bupropion Hydrochloride functions primarily as a Norepinephrine-Dopamine Reuptake Inhibitor (NDRI). This mechanism is defined by the inhibition of the neuronal reuptake of two specific chemical messengers: norepinephrine and dopamine. By blocking the reabsorption of these monoamines, the drug ensures higher concentrations remain available in the brain's synapses. The mechanism of Bupropion involves minimal serotonergic activity and focuses on its effect on both norepinephrine and dopamine reuptake. This medication targets two key chemicals linked to energy and motivation, which is often a differentiating factor in patient care.

The Significance of the Sustained-Release Tablet Form

The designation Retard is a key differentiating feature, signifying that the medication is a sustained-release (SR) formulation, supplied as a tablet for oral administration. This specific pharmaceutical preparation is engineered to release the Bupropion Hydrochloride gradually and continuously over several hours. This controlled delivery mechanism is designed to minimize fluctuations in the drug's plasma concentration throughout the day, which is associated with maintaining a more consistent therapeutic effect. The SR form supports the stability of the active substance's presence in the body over time.

Regulatory References

  1. NIH/MedlinePlus Drug Information
Advertisements

What side effects are possible with Wellbutrin Retard?

Possible side effects and safety information

Official regulatory documents classify the medicine's potential adverse reactions according to frequency and the body system affected. The most frequently reported effects, classified as Very Common (affecting more than 1 in 10 patients), include insomnia, headache, and dry mouth. Adverse reactions categorized as Common often involve the Gastrointestinal System (nausea, vomiting, constipation, abdominal pain) and the Nervous System (tremor, dizziness, anxiety, agitation), in addition to weight loss and increased blood pressure.

Serious Adverse Reactions and Safety Constraints

The label-documented serious risk is the potential for seizures or convulsions, which is dose-related. This risk is highest at the initiation of treatment and during dose escalation. Due to this factor, the medication is formally contraindicated in individuals with a history of seizure disorder or a current/prior diagnosis of bulimia or anorexia nervosa. Other serious reactions documented as Rare or Very Rare include severe hypersensitivity events, such as anaphylaxis, and potentially life-threatening cutaneous reactions like Stevens-Johnson Syndrome.

Safety statements also specify constraints for certain patient groups. Individuals with severe hepatic impairment are typically contraindicated due to the risk of drug accumulation, and caution is required for patients with renal impairment. The safety profile also includes the documented risk of new or worsened suicidal ideation and behavior, especially in children and adolescents, as stated in official labeling.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

This section summarizes the official regulatory information regarding the manifestations of Bupropion Hydrochloride overdose (contained in Wellbutrin Retard) and the mandated emergency actions.


Officially Documented Manifestations

The most serious acute manifestation documented in official labeling is seizures (convulsions), for which the risk is explicitly stated as dose-related. Other serious central nervous system and cardiovascular effects may include agitation, delirium, tachycardia (fast heart rate), coma, and hypertension. Severe outcomes can escalate to status epilepticus, life-threatening arrhythmias, and cardiogenic shock.

Due to the sustained-release nature of the tablet, the onset of seizures may be significantly delayed, occurring up to 24 hours after ingestion. This delayed toxicity is a key regulatory caution.

Required Emergency Actions

Immediate medical attention is required for any known or suspected overdose. Official guidelines mandate contacting a Poison Control center or emergency services right away.

  • No specific antidote is known for Bupropion overdose.
  • Management is strictly supportive and symptomatic.
  • The prolonged risk of seizures necessitates continuous monitoring of vital signs and an ECG (Electrocardiogram) during observation. Patients with reduced kidney or liver function may be at an increased risk of accumulation and related adverse effects.
Advertisements

Therapeutic Uses of Wellbutrin Retard

What Wellbutrin Retard Treats: Main Uses and Benefits

The medication is commonly used across conditions characterized by episodic or fluctuating symptom patterns in adults. The medicine is primarily indicated for the treatment of Major Depressive Disorder (MDD). It is also applied in clinical settings where supportive symptom management is appropriate to help individuals participating in a smoking cessation program.

The medication helps address symptom clusters that may become intense or disruptive, such as the lack of energy (anergia) and inability to experience pleasure (anhedonia) associated with depressive illness. It provides support that helps ease the overall symptom burden of low mood, emotional distress, and symptoms that interfere with daily functioning. For individuals with recurring Seasonal Affective Disorder (SAD), the medicine is applied during high-risk periods to assist with maintaining functional stability and help manage the potential for recurrent manifestations.

Quick Fact: Relief for Atypical Depression

The drug is commonly used to help manage depression where the primary symptoms are marked by hypersomnia (oversleeping) and significant fatigue, which is a common presentation in certain clinical scenarios.

Advertisements

Eligibility and Restrictions for Use

Eligibility for Wellbutrin Retard: Official Regulatory Status

Wellbutrin Retard (bupropion sustained-release) is approved for use in adults (18 years and older) for the labeled indications. Use in pediatric patients (under 18) is not established and generally not recommended for the treatment of depression. Older adults should be treated cautiously, often starting at a reduced dose.


Classification Population Status (Absolute Prohibition)
Contraindicated Patients with a seizure disorder or history of seizures.
Contraindicated Patients with a current or prior diagnosis of bulimia or anorexia nervosa.
Contraindicated Patients undergoing abrupt withdrawal from alcohol or sedatives.
Contraindicated Patients using a Monoamine Oxidase Inhibitor (MAOI) or any other product containing bupropion within 14 days.

Condition-Based Restrictions

The medicine's use is restricted and requires dose reduction in populations with impaired organ function. Patients with renal impairment or hepatic impairment require a lower dose or reduced dosing frequency due to altered clearance of the drug and its metabolites. Regarding pregnancy, use is generally not recommended unless necessary, and the drug is secreted into human milk during lactation.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information describes several key interaction categories for bupropion (the active ingredient in Wellbutrin Retard), primarily based on pharmacokinetic and pharmacodynamic mechanisms.

Contraindicated Combinations and Associated Constraints

Concomitant use with Monoamine Oxidase Inhibitors (MAOIs), including drugs such as linezolid and intravenous methylene blue, is contraindicated. A required 14-day washout period must pass after stopping an MAOI (used for psychiatric purposes) before starting bupropion, and vice versa. Use with other medicines containing bupropion is also restricted.

Pharmacokinetic Interactions (CYP Enzyme Effects)

Bupropion and its metabolites are a strong inhibitor of Cytochrome P450 2D6 (CYP2D6), an enzyme that metabolizes many other medicines. Co-administration can increase the concentration of medicines metabolized by CYP2D6, such as certain antidepressants (e.g., paroxetine, sertraline), antipsychotics (e.g., haloperidol), and beta-blockers (e.g., metoprolol). Dose reduction of the co-administered drug may be necessary.

Bupropion is metabolized by CYP2B6. Therefore, CYP2B6 inhibitors (e.g., ticlopidine) may increase bupropion exposure, while CYP2B6 inducers (e.g., ritonavir, carbamazepine) may decrease bupropion exposure, which may necessitate monitoring of clinical response.

Pharmacodynamic and Seizure Risk Interactions

Caution and close monitoring are required when bupropion is combined with other medicines that can lower the seizure threshold. This includes, but is not limited to, other medicines with this known risk. Caution is also advised when co-administering dopaminergic drugs (e.g., levodopa, amantadine) due to the potential for increased central nervous system (CNS) toxicity.

Advertisements

Mechanism of Action

Wellbutrin Retard (bupropion) functions primarily within the central nervous system by modulating specific catecholamine pathways. The drug and its active metabolites are classified as weak inhibitors of neuronal reuptake, resulting in targeted adjustments to key regulatory systems.

Targeting Dopamine and Norepinephrine Transporters

This mechanism involves the drug acting on the Dopamine Transporter (DAT) and the Norepinephrine Transporter (NET). By impeding the normal removal (reuptake) of these neurotransmitters from the synaptic space, the drug increases their concentration and sustains their signaling, which contributes to modulates signaling patterns within neural circuits.

Sustained Modulation via Active Metabolites

The full action is mediated by the parent drug and its active breakdown products, notably hydroxybupropion. These active metabolites support a sustained influence on DA/NE transporter activity throughout the day. This engagement within the active-metabolite mechanistic domain results in reduced clearance of mediators and induces downstream physiological adjustments that contributes to the overall action in the targeted pathways.

Advertisements

Dosage and Administration Information

The administration of Wellbutrin Retard (Bupropion Sustained-Release or SR tablets) is governed by specific instructions to ensure the drug's intended action over time.

Official Dosing and Administration

Administration Scope Official Requirement (Sustained-Release Form)
Route of Administration Oral administration; tablets must be swallowed whole and must not be crushed, divided, or chewed, a requirement of the sustained-release mechanism.
Frequency and Schedule Initial dosing is once daily (150 mg). Maintenance dosing is typically twice daily (150 mg) with an interval of at least 8 hours between successive doses.
Timing in Relation to Meals The tablets may be taken with or without food.
Missed-Dose Rules If a dose is missed, that dose should be skipped entirely. The patient should not take the missed dose and should take the next dose at the regularly scheduled time; the interval between doses must not be shortened.

Labeled Dosing Regimens for Adults

Indication Starting Dose Usual Target Dose Maximum Daily Dose
Major Depressive Disorder (MDD) 150 mg once daily 300 mg/day (150 mg twice daily) 400 mg/day (200 mg twice daily)
Smoking Cessation 150 mg once daily (for 3 days) 300 mg/day (150 mg twice daily) 300 mg/day

For the treatment of MDD, the total daily dose should not exceed 400 mg, and no single dose should exceed 200 mg.

Population-Specific Adjustments

Specific dosage modifications are advised for patients with altered renal or hepatic function. For patients with moderate to severe hepatic impairment, the maximum dose is restricted to 100 mg/day or 150 mg every other day. A dose or frequency reduction is also advised for patients with renal impairment (Glomerular Filtration Rate <90 mL/min).

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Wellbutrin Retard


Evidence for Use in Major Depressive Disorder (MDD)

Research examining Bupropion Sustained-Release in MDD primarily consists of short-term, placebo-controlled Randomized Controlled Trials (RCTs) and systematic reviews. These studies evaluated how symptoms change over defined time intervals in adult outpatients. The main outcomes monitored included the recording of changes in overall depressive symptom severity scores, with research also exploring metrics related to specific symptom patterns. Studies also monitored the recurrence of major depressive episodes during high-risk periods in individuals with Seasonal Affective Disorder (SAD). Findings describe patterns where the active treatment group recorded measured changes in severity scores that differed from the placebo groups in short-term studies. Further research explored the strategy of adding this medication in cohorts where initial monotherapy had not resulted in an adequate outcome.


Evidence for Use in Smoking Cessation

The research base for this medication was established in studies focused on smoking cessation and involved numerous randomized, double-blind, placebo-controlled trials. These studies focused on nicotine-dependent adults committed to quitting. Key outcomes monitored included the recording of continuous abstinence from smoking (often verified by biochemical testing) and the evaluation of patterns in withdrawal symptoms. Studies reported that the active treatment group recorded measurements of abstinence that differed from the placebo group over the first few months. Research also described that measurements of mean weight gain during the quitting phase differed between the active treatment group and the placebo group.


Research Gaps and Durability

Research has explored the longevity of the measured patterns in both indications. For MDD, studies monitored recurrence up to one year. However, evidence for the sustained effect after the medication is discontinued is more limited, with some studies describing that the recorded differences in smoking abstinence rates may diminish over the longest observation periods. Studies included cohorts of older adults for MDD and smokers with co-existing conditions, but data for certain groups, such as adolescents or pregnant women, remain insufficient. These findings describe group patterns, not personal outcomes, and research provides context but not individual predictions.

Key Studies & References Bupropion (Oral Route) - MedlinePlus Drug Information (NIH)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Wellbutrin Retard (FAQ)

Q: What happens if a person misses a dose of Wellbutrin Retard?

Regulatory safety documents specify that if a dose is missed, it should be skipped entirely, and the next dose should be taken at the regularly scheduled time. The guidance is that the interval between doses should not be shortened. This instruction is important to maintain the drug's sustained-release characteristics and minimize the potential for adverse effects.


Q: Can Wellbutrin Retard be used while breastfeeding or pregnant?

According to official product information, the drug is secreted into human milk during lactation. Its use during pregnancy is generally not recommended unless a potential benefit is determined to justify the possible risks. Considerations regarding use in these periods are detailed in the official product information.


Q: Is Wellbutrin Retard safe for older adults to use?

Official guidelines advise caution when treating older adults. They suggest that a dose reduction may be necessary due to the potential for increased accumulation of the drug and its metabolites (breakdown products) in the body.


Q: Is it possible for Wellbutrin Retard to affect blood pressure?

Yes, the medication can potentially cause elevated blood pressure (hypertension). Official labeling advises that blood pressure should be assessed before starting treatment and monitored periodically during therapy.


Q: What is the significance of the tablet being extended-release?

The sustained-release formulation is designed to release the active ingredient gradually and continuously over several hours. This controlled delivery is designed to help maintain consistent drug levels in the body, which is a factor considered in managing seizure risk.


Q: Are there official descriptions of what to do in case of an accidental overdose?

Regulatory safety information indicates that in cases of accidental overdose, immediate medical attention is required. Management is primarily supportive, and consultation with a regional poison control center is advised.


Q: Is Wellbutrin Retard used for conditions other than depression?

Yes, according to official labeling, the medication is approved for the treatment of Major Depressive Disorder (MDD) and is also approved for use as an aid to smoking cessation.


Q: Does Wellbutrin Retard take time to start working?

Clinical information indicates that initial effects may not begin to be observed for up to 14 days after starting therapy. The full therapeutic effect of the medication typically takes several weeks to become evident.


Q: What is the typical timeframe for seeing effects from Wellbutrin Retard?

Studies and official information indicate that a full evaluation of the drug's effectiveness is generally made after 4 to 8 weeks of consistent treatment.


Q: Can Wellbutrin Retard affect sleep patterns?

Regulatory documents list insomnia (difficulty sleeping) as a very common adverse reaction associated with use.


Q: Is weight change a possible outcome of using Wellbutrin Retard?

Yes. Regulatory documents classify weight loss as a common adverse reaction, indicating that changes in weight are a possible outcome of using the medication.


Q: Is it true that Wellbutrin Retard can affect appetite?

Regulatory documents list changes in appetite as a possible adverse reaction associated with the medication.


Q: Can taking Wellbutrin Retard cause anxiety or nervousness?

Official labeling lists both anxiety and nervous disturbance (nervousness) as common adverse reactions that have been reported during use of this medication.


Q: Is it normal to feel no changes in the first week of using this drug?

Yes, clinical information notes that initial effects may not be observed for up to two weeks, and the full benefit may require several weeks of consistent use.


Q: Does Wellbutrin Retard have any potential effect on focus or concentration?

Adverse reactions listed in regulatory documents include dizziness and a potential for poor concentration or difficulty with attention.


Q: Is there information about Wellbutrin Retard use in teenagers?

Official labeling states that the safety and effectiveness of the drug have not been established for use in children and adolescents under the age of 18.


Q: Can Wellbutrin Retard be taken at the same time as cold or allergy medicine?

Regulatory safety documents advise caution when using the medication with other drugs that affect the Central Nervous System (CNS), which may include certain cold or allergy medicines. Interactions are possible with drugs that lower the seizure threshold.


Q: Can Wellbutrin Retard be used with birth control pills?

Regulatory documents state that bupropion inhibits the enzyme CYP2D6, which is involved in the metabolism of many other medicines. This suggests a potential for altered concentration levels of co-administered drugs.


Q: Are there any known interactions between Wellbutrin Retard and herbal supplements?

The drug is metabolized by the CYP enzyme system; regulatory documents advise monitoring when used with agents that can affect this system, which may include certain herbal supplements that act as inducers or inhibitors.


Q: Is the medication designed to be taken once or twice a day?

The sustained-release formulation is designed to support a twice-daily dosing schedule for maintenance treatment of Major Depressive Disorder, following instructions for minimum time intervals between doses.


Q: What kind of safety information is available regarding long-term use of Wellbutrin Retard?

Clinical research has examined long-term use, particularly recurrence monitoring in Major Depressive Disorder (MDD), for periods of up to one year. Information on safety is available within this studied period.


Q: Can the medication affect a person's ability to drive?

Regulatory documents list central nervous system effects such as dizziness or drowsiness as potential adverse reactions that could affect tasks requiring mental alertness, such as driving or operating machinery.


Q: What are the reported major adverse events linked to Wellbutrin Retard?

Major documented serious adverse reactions include the potential for seizures and the risk of new or worsened suicidal ideation and behavior, particularly at the start of treatment or following a dose change.


Q: Is Wellbutrin Retard a controlled substance?

According to official regulatory classifications in the United States, the medication is not classified as a controlled substance.


Q: Does Wellbutrin Retard have potential interactions with painkillers?

Regulatory documents advise caution when combining the drug with other medicines that may lower the seizure threshold, or those that affect the Central Nervous System (CNS), which includes certain types of painkillers.


Q: Can Wellbutrin Retard cause mouth dryness?

Yes. Regulatory documents classify dry mouth as a very common adverse reaction, meaning it affects more than 1 in 10 patients.


Q: What are the general expectations about discontinuing the medication?

Official information describes that the discontinuation of the medication, as with other antidepressants, involves gradual reduction to monitor for potential effects.


Q: Is there a maximum amount of time someone is approved to use Wellbutrin Retard?

Official guidelines suggest treating patients with depression for a period of at least six months to support symptom-free status. No explicit overall maximum duration limit is generally stated.

Advertisements

How should Wellbutrin Retard be stored and disposed of?

Wellbutrin Retard (bupropion hydrochloride sustained-release tablets) must be stored under specific, controlled conditions to maintain product stability and ensure household safety, as mandated by regulatory authorities.

Official Storage Requirements

The tablets require storage at controlled room temperature, typically defined as 20 C to 25 C (68 F to 77 F). The medication must be kept in its original container and the container must be kept tightly closed to protect the contents from moisture and light. It is a mandatory safety instruction to store this medicine out of the reach of children.

Disposal Instructions

Unused or expired tablets should be disposed of in a manner that prevents environmental release. The preferred method is to utilize a community-based drug take-back program. If a take-back option is unavailable, the product must be mixed with an undesirable substance (such as used coffee grounds or kitty litter) and sealed in a container before being placed in household trash. This medicine should not be flushed down a toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Wellbutrin Retard found in:

A-Z Index: